MedTech Dive July 8, 2024
A company spokesperson said the decision follows a recent review and reflects a push to improve operational efficiency.
Dive Brief:
- BD plans to wind down operations at a plant in Ireland over the next 2 1/2 years, a company spokesperson said Wednesday in an emailed statement to MedTech Dive.
- The phased closure of the Drogheda facility, which makes oncology, interventional radiology and critical care products, could result in the loss of around 170 jobs.
- BD’s spokesperson said the decision follows a recent review and reflects an attempt to ensure all operations are efficient and resources “are allocated in the most effective manner possible.” The spokesperson added that there would be no impact at BD’s other facilities in Ireland.